Stem cells therapy for regenerative medicine: Principles of present and future practice — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Stem cells therapy for regenerative medicine: Principles of present and future practice
Laboratory of Bioengineering and Tissue Regeneration (LABRET), Department of Cell Biology, Genetics and Physiology, Faculty of Sciences, IBIMA, University of Málaga, Málaga, Spain; Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Málaga, Spain
,
Laboratory of Bioengineering and Tissue Regeneration (LABRET), Department of Cell Biology, Genetics and Physiology, Faculty of Sciences, IBIMA, University of Málaga, Málaga, Spain; Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Málaga, Spain; Andalusian Centre for Biotechnology and Nanomedicine (BIONAND), Parque Tecnológico de Andalucía, Campanillas, Málaga, Spain
,
Department of Animal Biology, Faculty of Sciences, University of Málaga, Málaga, Spain
,
Institute of Neurosciences, University of Miguel Hernández, Alicante, Spain
,
Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Málaga, Spain; Control of Stem Cell Potency Group, Institut for Bioengineering of Catalonia (IBEC), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), P. Lluís Companys, Barcelona, Spain
,
Institute of Molecular Biology and Genetics (IBGM), University of Valladolid, Valladolid, Spain
,
Unit of Transplant and Cell Therapy, University of Murcia, IMIB, University Clinic Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain
1 Laboratory of Bioengineering and Tissue Regeneration (LABRET), Department of Cell Biology, Genetics and Physiology, Faculty of Sciences, IBIMA, University of Málaga, Málaga, Spain; Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Málaga, Spain
2 Laboratory of Bioengineering and Tissue Regeneration (LABRET), Department of Cell Biology, Genetics and Physiology, Faculty of Sciences, IBIMA, University of Málaga, Málaga, Spain; Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Málaga, Spain; Andalusian Centre for Biotechnology and Nanomedicine (BIONAND), Parque Tecnológico de Andalucía, Campanillas, Málaga, Spain
3 Department of Animal Biology, Faculty of Sciences, University of Málaga, Málaga, Spain
4 Institute of Neurosciences, University of Miguel Hernández, Alicante, Spain
5 Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Málaga, Spain; Control of Stem Cell Potency Group, Institut for Bioengineering of Catalonia (IBEC), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), P. Lluís Companys, Barcelona, Spain
6 Institute of Molecular Biology and Genetics (IBGM), University of Valladolid, Valladolid, Spain
7 Unit of Transplant and Cell Therapy, University of Murcia, IMIB, University Clinic Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain
The characterization and isolation of various stem cell populations, from embryonic to tissue-derived stem cells and induced pluripotent stem cells (iPSCs), have led to a rapid growth in the field of stem cell research and its potentially clinical application in the field of regenerative medicine and tissue repair. Stem cell therapy has recently progressed from the preclinical to the early clinical trial arena for a variety of diseases states, although further knowledge on action mechanisms, long-term safety issues, and standardization and characterization of the therapeutic cell products remains to be thoroughly elucidated. In this paper we summarize the current state of the art of basic and clinical research that were highlighted at the 2012 meeting of the Spanish Cell Therapy Network. This includes the current research involving in genomic and transcriptomic characterization of selected stem cell populations, studies of the role of resident and transplanted stem cells during tissue regeneration and their mechanism of action, improved new strategies of tissue engineering, transplantation of mesenchymal stem cells (MSCs) in different animal models of disease, disease correction by iPSCs, and preliminary results of cell therapy in human clinical trials.
KeywordsSpanish Cell Therapy NetworkStem CellCell TherapyTissue EngineeringRegenerative Medicine
Sipp, D. (2011) Global challenges in stem cell research and the many roads ahead. Neuron, 70, 573-576. http://dx.doi.org/10.1016/j.neuron.2011.05.008
Trounson, A. and Dewitt, N.D. (2012) Stem cell biology: Towards the reality of cell therapeutics. Nature Cell Biology, 14, 331. http://dx.doi.org/10.1038/ncb2469
Mustafiz, T., Portelius, E., Gustavsson, M.K., et al. (2010) Characterization of the brain beta-amyloid isoform pattern at different ages of Tg2576 mice. Neurodegenerative Diseases, 8, 352-363. http://dx.doi.org/10.1159/000323871
Kordower, J.H. (2008) Introduction to the special ASNTR issue. Cell Transplantation, 17, 361-362.
Cicchetti, F., Drouin-Ouellet, J. and Gross, R.E. (2009) Environmental toxins and Parkinson’s disease: What have we learned from pesticide-induced animal models? Trends of Pharmacology Science, 30, 475-483. http://dx.doi.org/10.1016/j.tips.2009.06.005
Ekdahl, C.T., Kokaia, Z. and Lindvall, O. (2009) Brain inflammation and adult neurogenesis: The dual role of microglia. Neuroscience, 158, 1021-1029. http://dx.doi.org/10.1016/j.neuroscience.2008.06.052
Arvidsson, L., Fagerlund, M., Jaff, N., et al. (2011) Distribution and characterization of progenitor cells within the human filum terminale. PloS One, 6, e27393. http://dx.doi.org/10.1371/journal.pone.0027393
Ekdahl, C.T. (2012) Microglial activation-tuning and pruning adult neurogenesis. Frontier of Pharmacology, 3, 41. http://dx.doi.org/10.3389/fphar.2012.00041
Winner, B., Kohl, Z. and Gage, F.H. (2011) Neurodegenerative disease and adult neurogenesis. European Journal of Neuroscience, 33, 1139-1151. http://dx.doi.org/10.1111/j.1460-9568.2011.07613.x
Blanquer, M., Pérez-Espejo, M.A., Martínez-Lage, J.F., et al. (2010) A surgical technique of spinal cord cell transplantation in amyotrophic lateral sclerosis. Journal of Neuroscience Methods, 191, 255-257. http://dx.doi.org/10.1016/j.jneumeth.2010.06.014
Blanquer, M., Moraleda, J.M., Iniesta, F., et al. (2012) Neurotrophic bone marrow celular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: A pilot safety study. Stem Cells, 30, 1277-1285. http://dx.doi.org/10.1002/stem.1080
Araque-Monrós, M.C., Gil-Santos, L., Monleón-Pradas, M. and Más-Estellés, J. (In press) New concept for a regenerative and resorbable prosthesis for tendon and ligament. Physicochemical and biological characterization of PLA braided biomaterial. Journal of Biomedical Materials Research: Part A.
Andrades, J.A., Motaung, S.C., Jiménez-Palomo, P., et al. (2012) Induction of superficial zone protein (SZP)/lubricin/PRG 4 in muscle-derived mesenchymal stem/progenitor cells by transforming growth factor-beta1 and bone morphogenetic protein-7. Arthritis Research and Therapy, 14, 31-42. http://dx.doi.org/10.1186/ar3793
Granero-Moltó, F., Weis, J.A., Miga, M.I., et al. (2009) Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells, 27, 1887-1898. http://dx.doi.org/10.1002/stem.103
Evans, C.H. (2013) Advances in regenerative orthopedics. Mayo Clinic Proceedings, 88, 1323-1339. http://dx.doi.org/10.1016/j.mayocp.2013.04.027
Orozco, L., Soler, R., Morera, C., et al. (2011) Intervertebral disc repair by autologous mesenchymal bone marrow cells: A pilot study. Transplantation, 92, 822-828. http://dx.doi.org/10.1097/TP.0b013e3182298a15
Gallego, L., Junquera, L., García, E., et al. (2010) Repair of rat mandibular bone defects by alveolar osteoblasts in a novel plasma-derived albumin scaffold. Tissue Engineering Part A, 16, 1179-1187. http://dx.doi.org/10.1089/ten.tea.2009.0517
Le Blanc, K. and Ringden, O. (2007) Immunomodulation by mesenchymal stem cells and clinical experience. Journal of International Medicine, 262, 509-525. http://dx.doi.org/10.1111/j.1365-2796.2007.01844.x
Chang, C.H., Kuo, T.F., Lin, F.H., et al. (2011) Tissue engineering-based cartilage repair with mesenchymal stem cells in a porcine model. Journal of Orthopaedic Research, 29, 1874-1880. http://dx.doi.org/10.1002/jor.21461
Bernardo, M.E., Pagliara, D. and Locatelli, F. (2011) Mesenchymal stromal cell therapy: A revolution in Regenerative Medicine? Bone Marrow Transplantation, 47, 164-171. http://dx.doi.org/10.1038/bmt.2011.81
Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676. http://dx.doi.org/10.1016/j.cell.2006.07.024
Vogel, G. (2010) Stem cells. Reprogrammed cells come up short, for now. Science, 327, 1191-1197.
Graf, T. and Enver, T. (2009) Forcing cells to change lineages. Nature, 462, 587-594. http://dx.doi.org/10.1038/nature08533
Vierbuchen, T. and Wernig, M. (2011) Direct lineage conversions: Unnatural but useful? Nature Biotechnology, 29, 892-907. http://dx.doi.org/10.1038/nbt.1946
Mizrak, S.C., Chikhovskaya, J.V., Sadri-Ardekani, H., et al. (2009) Embryonic stem cell-like cells derived from adult human testis. Human Reproduction, 25, 158-167. http://dx.doi.org/10.1093/humrep/dep354
Aasen, T., Raya, A., Barrero, M.J., et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature Biotechnology, 26, 1276-1284. http://dx.doi.org/10.1038/nbt.1503
Giorgetti, A., Montserrat, N., Aasen, T., et al. (2009) Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell, 5, 353-357. http://dx.doi.org/10.1016/j.stem.2009.09.008
Ebert, A.D., Yu, J., Rose, F.F., et al. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457, 277-280. http://dx.doi.org/10.1038/nature07677
Lee, H., Park, J., Forget, B.G. and Gaines, P. (2009) Induced pluripotent stem cells in regenerative medicine: An argument for continued research on human embryonic stem cells. Regenerative Medicine, 4, 759-769. http://dx.doi.org/10.2217/rme.09.46
Carvajal-Vergara, X., Sevilla, A., D’Souzza, S.L., et al. (2010) Patient-specific induced pluripotent stem-cell derived models of LEOPARD syndrome. Nature, 465, 808-812. http://dx.doi.org/10.1038/nature09005
Ku, S., Soragni, E., Campau, E., Thomas, E.A., Altun, G., Laurent, L.C., Loring, J.F., Napierala, M. and Gottesfeld, J.M. (2010) Friedreich’s ataxia induced pluripotent stem cells model intergenerational GAA-TTC triplet repeat instability. Cell Stem Cell, 7, 631-637. http://dx.doi.org/10.1016/j.stem.2010.09.014
Moretti, A., Bellin, M., Welling, A., et al. (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. New England Journal of Medicine, 363, 1397-1409. http://dx.doi.org/10.1056/NEJMoa0908679
Rashid, S.T., Corbineau, S., Hannan, N., Marciniak, S.J., Miranda, E., Alexander, G., Huang-Doran, I., Griffin, J., Ahrlund-Richter, L., Skepper, J., Semple, R., Weber, A., Lomas, D.A. and Vallier, L. (2010) Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. Journal of Clinical Investigation, 120, 3127-3136. http://dx.doi.org/10.1172/JCI43122
Zhang, S., Chen, S., Li, W., Guo, X.P., Zhao, P., Xu, J.Y., Chen, Y., Pan, Q., Liu, X.R., Zychlinski, D., Lu, H., Tortorella, M.D., Schambach, A., Wang, Y., Pei, D.Q. and Esteban, M.A. (2011) Rescue of ATP7B function in hepatocyte-like cells from Wilson’s disease induced pluri-potent stem cells using gene therapy or the chaperone drug curcumin. Human Molecular Genetics, 20, 3176-3187. http://dx.doi.org/10.1093/hmg/ddr223
Brennand, K.J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y.L., Chen, G., Yu, D., McCarthy, S., Sebat, J. and Gage, F.H. (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature, 473, 221-225. http://dx.doi.org/10.1038/nature09915
Sánchez-Danés, A., Richaud-Patin, Y., Carballo-Carbajal, I., Jiménez-Delgado, S., Caig, C., Mora, S., Di Guglielmo, C., Ezquerra, M., Patel, B., Giralt, A., Canals, J.M., Memo, M., Alberch, J., López-Barneo, J., Vila, M., Cuervo, A.M., Tolosa, E., Consiglio, A. and Raya, A. (2012) Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease. EMBO Molecular Medicine, 4, 380-395. http://dx.doi.org/10.1002/emmm.201200215
Raya, A., Rodríguez-Pizá, I., Guenechea, G., Vassena, R., Navarro, S., Barrero, M.J., Consiglio, A., Castellà, M., Río, P., Sleep, E., González, F., Tiscornia, G., Garreta, E., Aasen, T., Veiga, A., Verma, I.M., Surrallés, J., Bueren, J. and Belmonte, J.C.I. (2009) Disease-corrected haematopoietic progenitors from Falconi anaemia induced pluri-potent stem cells. Nature, 460, 53-59. http://dx.doi.org/10.1038/nature08129
Ma, N., Liao, B., Zhang, H., et al. (2013) TALEN-mediated gene correction in integration-free-beta-thalassemia iPSCs. Journal of Biology and Chemistry, Epub ahead of print.
Perez-Pinera, P., Ousterout, D.G. and Gersbach, C.A. (2012) Advances in targeted genome editing. Current Opinion in Chemical Biology, 16, 268-277. http://dx.doi.org/10.1016/j.cbpa.2012.06.007
Okano, H., Nakamura, M., Yoshida, K., Okada, Y., Tsuji, O., Nori, S., Ikeda, E., Yamanaka, S. and Miura, K. (2013) Steps toward safe cell therapy using induced pluripotent stem cells. Circulation Research, 112, 523-533. http://dx.doi.org/10.1161/CIRCRESAHA.111.256149
Ronen, D. and Benvenisty, N. (2012) Genomic stability in reprogramming. Current Opinion in Genetics & Development, 22, 444-449. http://dx.doi.org/10.1016/j.gde.2012.09.003
Cyranoski, D. (2013) Stem cells cruise to clinic. Nature, 494, 413. http://dx.doi.org/10.1038/494413a
Cyranoski, D. (2012) Stem-cell pioneer banks on future therapies. Nature, 488, 139. http://dx.doi.org/10.1038/488139a